The Contribution of Galenics to Patients' Sensory Perception of Nasal Sprays After Nasal Surgery: Data from a Prospective Randomised, Controlled, Double-Blind, Crossover, Multicentre Study.
Christoph BergmannJennifer LanderLea RadtkeLaura EnglandJaswinder SinghRalph MosgesPublished in: Advances in therapy (2021)
The current study was registered in the EU Clinical Trials Register with the EudraCT No. 2019-004936-52.
Keyphrases
- clinical trial
- double blind
- end stage renal disease
- ejection fraction
- chronic kidney disease
- placebo controlled
- newly diagnosed
- minimally invasive
- study protocol
- peritoneal dialysis
- prognostic factors
- open label
- chronic rhinosinusitis
- coronary artery bypass
- patient reported outcomes
- coronary artery disease
- atrial fibrillation